| For: | Jacobs AK, Morley SD, Samuel K, Morgan K, Boswell L, Kendall TJ, Dorward DA, Fallowfield JA, Hayes PC, Plevris JN. Hepatic angiotensin-converting enzyme 2 expression in metabolic dysfunction-associated steatotic liver disease and in patients with fatal COVID-19. World J Gastroenterol 2024; 30(31): 3705-3716 [PMID: 39192998 DOI: 10.3748/wjg.v30.i31.3705] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v30/i31/3705.htm |
| Number | Citing Articles |
| 1 |
Sara Elizabeth Stinson, Yun Huang, Roman Thielemann, Evelina Stankevic, Morten Asp Vonsild Lund, Louise Aas Holm, Cilius Esmann Fonvig, Helene Bæk Juel, Dmitrii Borisevich, Maja Thiele, Aleksander Krag, Lars Ängquist, Thorkild I. A. Sørensen, Oluf Pedersen, Michael Christiansen, Jens-Christian Holm, Torben Hansen. Identification of modifiable plasma protein markers of cardiometabolic risk in children and adolescents with obesity. Nature Communications 2026; 17(1) doi: 10.1038/s41467-026-68415-2
|
| 2 |
Cintia Cevallos, Patricio Jarmoluk, Franco Sviercz, Rosa Nicole Freiberger, Cynthia Alicia Marcela López, M. Victoria Delpino, Jorge Quarleri. Ferroptosis and mitochondrial ROS are central to SARS-CoV-2-induced hepatocyte death. Frontiers in Cellular and Infection Microbiology 2025; 15 doi: 10.3389/fcimb.2025.1625928
|
| 3 |
Ilze Strumfa, Ludmila Viksna, Oksana Kolesova, Ieva Vanaga, Haralds Plaudis, Jelena Storozenko, Boriss Strumfs, Janis Pavulans, Romans Uljanovs. Morphological and Immunohistochemical Characteristics of Liver Inflammation in Patients with a History of COVID-19. Viruses 2026; 18(1): 68 doi: 10.3390/v18010068
|
| 4 |
Yu-Wei Luo, Ai-Long Huang, Kai-Fu Tang. Angiotensin-converting enzyme 2 and hepatic SARS-CoV-2 infection: Regulation, association, and therapeutic implications. World Journal of Gastroenterology 2025; 31(6): 100864 doi: 10.3748/wjg.v31.i6.100864
|
| 5 |
Lu Jiang, Jian-Gao Fan. Gut microbiota in gastrointestinal diseases: Insights and therapeutic strategies. World Journal of Gastroenterology 2024; 30(39): 4329-4332 doi: 10.3748/wjg.v30.i39.4329
|
| 6 |
Aurelio Seidita, Carola Buscemi, Diana Di Liberto, Mirco Pistone, Salvatore Maestri, Giorgia Cavallo, Salvatore Cosenza, Gabriele Spagnuolo, Alessandra Giuliano, Daniela Carlisi, Giovanni Pratelli, Francesca Mandreucci, Antonio Carroccio. Angiotensin-Converting Enzyme Inhibitors to Prevent Liver Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: Scientific Speculation or an Opportunity to Improve Real Clinical Practice?. International Journal of Molecular Sciences 2025; 26(24): 11782 doi: 10.3390/ijms262411782
|
